Carnitine-esters from the mushroom Suillus laricinus

Phytochemistry

Volumn 67, Issue 24, 2006, Pages 2676-2680

  Kawagishi, Hirokazu ^a   Murakami, Hiroaki ^a   Sakai, Shingo ^b   Inoue, Shintaro ^b  

^a SHIZUOKA UNIVERSITY   (Japan)

^b Kanebo Cosmetics Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; ESTER; HYALURONIC ACID;

ARTICLE; BASIDIOMYCETES; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; FIBROBLAST; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

BASIDIOMYCOTA; CARNITINE; CELL LINE; ESTERS; FIBROBLASTS; HUMANS; HYALURONIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT;

BASIDIOMYCOTA; SUILLUS LARICINUS;

EID: 33751195509     PISSN: 00319422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phytochem.2006.09.014     Document Type: Article

References (24)

1. Duncombe W.G., and Rising T.J. Hypoglycemic compound cyclopropanecarboxylic acid. Effects on fatty acid oxidation in vitro. Biochem. Pharm. 21 (1972) 1075-1088
2. ElMaradny E., Kanayama N., Kobayashi H., Hossain B., Khatun S., Liping S., Kobayashi T., and Terao T. The role of hyaluronic acid as a mediator and regulator of cervical ripening. Hum. Reprod. 12 (1997) 1080-1088
3. Fukao T. The mitochondrial acetoacetyl-CoA thiolase (T2) deficiency in Japanese patients: urinary organic acid and blood acylcarnitine profiles under stable conditions have subtle abnormalities in T2-deficient patients with some residual T2 activity. J. Inherit. Metabolic Disease 26 (2003) 423-431
4. Guilbert C.C.l., and Chung A.E. Metabolism of cyclopropanecarboxylic acid. New role for carnitine. J. Biol. Chem. 249 (1974) 1026-1030
5. Holland P.C., and Sherratt H.S.A. Biochemical effects of the hypoglycemic compound 4-pentenoic acid and related nonhypoglycemic fatty acids. Effects of the free acids and their carnitine esters on coenzyme A-dependent oxidations in rat liver mitochondria. Biochem. J. 136 (1973) 157-171
6. Itano N., Sawai T., Miyaishi O., and Kimata K. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res. 59 (1999) 2499-2504
7. Jacobson A., Rahmanian M., Rubin K., and Heldin P. Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int. J. Cancer 102 (2002) 212-219
8. Kawagishi H., Tonomura Y., Yoshida H., Sakai S., and Inoue S. Orirubenones A, B and C, novel hyaluronan-degradation inhibitors from the mushroom Tricholoma orirubens. Tetrahedron. 60 (2004) 7049-7052
9. Koeberl D.D., Millington D.S., Smith W.E., Weavil S.D., Muenzer J., McCandless S.E., Kishnani P.S., McDonald M.T., Chaing S., Boney A., Moore E., and Frazier D.M. Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening. J. Inherit. Metabolic Disease 26 (2003) 25-35
10. Paul, H.S., 2000. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin. International patent No. WO2000004870.
11. Quistad G.B., Staiger L.E., and Schooley D.A. Environmental degradation of the miticide cycloprate (hexadecyl cyclopropanecarboxylate). 1. Rat metabolism. J Agric. Food Chem. 26 (1978) 60-66
12. Quistad G.B., Staiger L.E., and Schooley D.A. Environmental degradation of the miticide cycloprate (hexadecyl cyclopropanecarboxylate). 3. Bovine metabolism. .J Agric. Food Chem. 26 (1978) 71-75
13. Quistad G.B., Staiger L.E., and Schooley D.A. Environmental degradation of the miticide cycloprate (hexadecylcyclopropanecarbox ylate). 4. Beagle dog metabolism. J Agric. Food Chem. 26 (1978) 76-80
14. Quistad G.B., Staiger L.E., Schooley D.A., Sparks T.C., and Hammock B.D. The possible role of carnitine in the selective toxicity of the miticide cycloprate Pestic. Biochem. Phys. 11 (1979) 159-165
15. Quistad G.B., Staiger L.E., and Schooley D.A. The role of carnitine in the conjugation of acidic xenobiotics. Drug Metab. Dispos. 14 (1986) 521-525
16. Rai S.K., Duh F.M., Vigdorovich V., Danilkovitch-Miagkova A., Lerman M.I., and Miller A.D. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc. Natl. Acad. Sci. USA 98 (2001) 4443-4448
17. Rashed M.S., Ozand P.T., Bucknall M.P., and Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr. Res. 38 (1995) 324-331
18. Roeschinger W., Millington D.S., Gage D.A., Huang Z.-H., Iwamoto T., Yano S., Packman S., Johnston K., and Berry S.A. 3-Hydroxyisovalerylcarnitine in patients with deficiency of 3-methylcrotonyl CoA carboxylase. Clin. Chim. Acta 240 (1885) 31-35
19. Sakai S., Tonomura Y., Yoshida H., Inoue S., and Kawagishi H. Orirubenones D to G, novel phenones from the Tricholoma orirubens mushroom. Biosci. Biotechnol. Biochem. 69 (2005) 1630-1632
20. Satoh T., Ichida T., Matsuda Y., Sugiyama M., Yonekura K., Ishikawa T., and Asakura H. Interaction between hyaluronan and CD44 in the development of dimethylnitrosamine-induced liver cirrhosis. J. Gastroenterol. Hepatol. 15 (2000) 402-411
21. Shigematsu Y., Bykov I.L.L.Y.Y., Nakai A., Kikawa Y., Sudo M., and Fujioka M. Acylcarnitine profile in tissues and body fluids of biotin-deficient rats with and without L-carnitine supplementation. J. Inherit. Metabolic Disease 17 (1994) 678-690
22. Silva M.F.B., Selhorst J., Overmars H., van Gennip A.H., Maya M., Wanders R.J.A., Tavares de Almeida I., and Duran M. Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS. Clinic. Biochem. 34 (2001) 635-638
23. Underhill C.B., and Toole B.P. Binding of hyaluronate to the surface of cultured cells. J. Cell. Biol. 82 (1979) 475-484
24. Zytkovicz T.H., Fitzgerald E.F., Marsden D., Larson C.A., Shih V.E., Johnson D.M., Strauss A.W., Comeau A.M., Eaton R.B., and Grady G.F. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clinic. Chem. 47 (2001) 1945-1955